Skip to content
RPIDRapid Micro Biosystems, Inc.

Earnings

When Rapid Micro Biosystems, Inc. reports, what it reported each quarter, and how the stock took the results.

26 quarters. Mar 31, 2020 to Jun 30, 2026. USD.

Next results · Q3 2026Released

Yesterday, during market hours

Mon, Nov 16, 20261 day ago

The results are out. The figures reach the desk with the 10-Q.

Quarter
Q3 2026 · Ended Sep 30, 2026
10-Q window
Oct 30 – Nov 13

Read against Q3 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$7.84M
Revenue, change from a year earlier: Q2 2026 +10.9%, Q1 2026 +11.1%, Q4 2025 +37.3%, Q3 2025 +3.1%
Net income
-$11.51M
Net income, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m, Q3 2025 n/m
EPS
-$0.26
EPS, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m, Q2 2025 n/m

Quarter by quarter

Q2 2026$8.05M+10.9% vs Q2 2025

Latest results

  1. Q2 2026Aug 7, 2026, before the openThe release16.8%by the close of Aug 7
    Revenue
    $8.05M
    +10.9%
    Net income
    -$12.92M
    N/M
    EPS
    -$0.27
    N/M
  2. Q1 2026May 13, 2026, after the closeThe release7.6%by the close of May 14
    Revenue
    $8.00M
    +11.1%
    Net income
    -$14.28M
    N/M
    EPS
    -$0.31
    N/M
  3. Q4 2025Mar 12, 2026, before the openThe release22.1%by the close of Mar 12
    Revenue
    $11.28M
    +37.3%
    Net income
    -$12.50M
    N/M
    EPS
    —
    —
  4. Q3 2025Nov 7, 2025, before the openThe release+9.2%by the close of Nov 7
    Revenue
    $7.84M
    +3.1%
    Net income
    -$11.51M
    N/M
    EPS
    -$0.26
    N/M

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q2 2026Jun 30, 2026Aug 7, 2026 · pre-marketAug 7, 202638 d10-Q$8.05M+10.9%-$0.2716.8%
Q1 2026Mar 31, 2026May 13, 2026 · after-hoursMay 15, 202645 d10-Q$8.00M+11.1%-$0.317.6%
FY 2025
Q4 2025derivedDec 31, 2025Mar 12, 2026 · pre-marketMar 12, 202671 d10-K$11.28M+37.3%—22.1%
Q3 2025Sep 30, 2025Nov 7, 2025 · pre-marketNov 7, 202538 d10-Q$7.84M+3.1%-$0.26+9.2%
Q2 2025Jun 30, 2025Aug 12, 2025 · pre-marketAug 12, 202543 d10-Q$7.26M+9.7%-$0.2721.2%
Q1 2025Mar 31, 2025May 9, 2025 · pre-marketMay 9, 202539 d10-Q$7.21M+28.4%-$0.26+26.5%
FY 2024
Q4 2024derivedDec 31, 2024Feb 28, 2025 · pre-marketFeb 28, 202559 d10-K$8.22M+29.7%—7.9%
Q3 2024Sep 30, 2024Nov 1, 2024 · pre-marketNov 7, 202438 d10-Q$7.60M+23.7%-$0.26+0.5%
Q2 2024Jun 30, 2024Aug 2, 2024 · pre-marketAug 2, 202433 d10-Q$6.62M+32.3%-$0.29—
Q1 2024Mar 31, 2024May 3, 2024 · pre-marketMay 3, 202433 d10-Q$5.61M+11.4%-$0.31—
Earlier years, FY 2020 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QAug 7, 2026000101
10-QMay 15, 2026000075
10-KMar 12, 2026000034
10-QNov 7, 2025000200
10-QAug 12, 2025000174
10-QMay 9, 2025000102
10-KFeb 28, 2025000058
10-QNov 7, 2024000197
10-QAug 2, 2024000166
10-QMay 3, 2024000127

Provenance

ProvenanceData status and checks

Rapid Micro Biosystems, Inc. · CIK 1380106 · Engraved from SEC EDGAR